meetings for healthcare professionals initiated and fully funded by Eisai
First Thoughts Renal Cell Carcinoma (RCC) Meeting 2022
The ever-changing landscape in RCC
The Royal College of Physicians
11 St Andrews Place, London NW1 4LE
The Royal College of Physicians
11 St Andrews Place, London NW1 4LE
Dear Partners in RCC,
On behalf of Eisai, I am writing to invite you to the first in-person ‘First Thoughts RCC’ meeting.
This meeting is for oncologists, CNSs and pharmacists from across the UK and will provide the most recent update on the management of RCC. The agenda is highly topical, addressing the reality we all face in clinical practice.
I would like to formally acknowledge the critical support of our Steering Committee members in designing the RCC Agenda, and the panel of experts presenting on the day.
We hope that you will accept this invitation to join us at the ‘First Thoughts RCC’ meeting.
Many thanks.
Professor Tom Powles
Professor Tom Powles, MBBS, MRCP, MD
Professor of Genitourinary Oncology Director, Barts Cancer Centre, London
CPD accreditation has been applied for.
Kisplyx (lenvatinib) (RCC) Prescribing Information
Oncologist, Barts Cancer Centre, London
Oncologist, Edinburgh Cancer Centre, Edinburgh
Oncologist, Mount Vernon Cancer Centre, Northwood
Urologist, Addenbrooke’s Hospital, Cambridge
CNS, Guy’s and St Thomas’, London
Date of preparation: March 2022 | Job Code: UK-KIS-21-00107